文献速递乳腺乳腺X线

对比增强乳腺X线摄影(CEM)的当前应用与未来前景:欧洲乳腺影像学会(EUSOBI)调查

Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI).
PubMed 文献 · Eur Radiol · 2024-01-16

该调查向欧洲乳腺影像学会(EUSOBI)成员发放问卷,了解对比增强乳腺X线摄影(CEM)的应用情况。434名受访者中50%使用CEM,最常见指征为MRI禁忌患者(80.6%);使用CEM及经验更丰富者报告的当前和未来指征显著更多。

要点

  • 50%受访者(217/434)在临床使用CEM,其中71.4%(155/217)年检查量少于200例。
  • 当前最常见指征为MRI禁忌患者(80.6%),其次为术前分期(68.7%)。
  • 未来最常见预期指征仍为MRI禁忌患者(88.0%),其次为无对比增强检查结论不明确者的进一步评估(61.5%)和致密乳腺的补充影像(53.0%)。

核心结论

  • 尽管CEM应用趋向学术机构和高工作量环境,且主要用于MRI禁忌患者,但CEM使用和逐步积累的经验与对该技术信心的增加相关。

研究设计与样本

  • 由九名委员会认证放射科医生组成的小组开发29项在线问卷,于2023年1月25日至3月10日分发给所有EUSOBI成员(欧洲及欧洲以外),共434名受访者(74.9%来自欧洲),采用描述性和非参数统计进行探索性分析。

诊断标准与关键数值

  • 50%(217/434)受访者表示使用CEM。
  • 155/217(71.4%)受访者每年CEM检查量少于200例。
  • 未采用CEM最常见原因为认为缺乏临床需求(65.0%)和缺乏资源购置具备CEM功能的系统(37.3%)。
  • 61.3%受访者已采用2022 ACR CEM BI-RADS®词典。
  • CEM使用与学术机构和高乳腺影像工作量相关(p < 0.001)。

临床应用与阅片要点

  • 使用CEM且CEM经验更丰富的受访者报告的当前指征显著更多(p = 0.004)。
  • 使用CEM且CEM经验更丰富的受访者报告的未来指征显著更多(p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To perform a survey among members of the European Society of Breast Imaging (EUSOBI) regarding the use of contrast-enhanced mammography (CEM).

METHODS: A panel of nine board-certified radiologists developed a 29-item online questionnaire, distributed to all EUSOBI members (inside and outside Europe) from January 25 to March 10, 2023. CEM implementation, examination protocols, reporting strategies, and current and future CEM indications were investigated. Replies were exploratively analyzed with descriptive and non-parametric statistics.

RESULTS: Among 434 respondents (74.9% from Europe), 50% (217/434) declared to use CEM, 155/217 (71.4%) seeing less than 200 CEMs per year. CEM use was associated with academic settings and high breast imaging workload (p < 0.001). The lack of CEM adoption was most commonly due to the perceived absence of a clinical need (65.0%) and the lack of resources to acquire CEM-capable systems (37.3%). CEM protocols varied widely, but most respondents (61.3%) had already adopted the 2022 ACR CEM BI-RADS® lexicon. CEM use in patients with contraindications to MRI was the most common current indication (80.6%), followed by preoperative staging (68.7%). Patients with MRI contraindications also represented the most commonly foreseen CEM indication (88.0%), followed by the work-up of inconclusive findings at non-contrast examinations (61.5%) and supplemental imaging in dense breasts (53.0%). Respondents declaring CEM use and higher CEM experience gave significantly more current (p = 0.004) and future indications (p < 0.001).

CONCLUSIONS: Despite a trend towards academic high-workload settings and its prevalent use in patients with MRI contraindications, CEM use and progressive experience were associated with increased confidence in the technique.

CLINICAL RELEVANCE STATEMENT: In this first survey on contrast-enhanced mammography (CEM) use and perspectives among the European Society of Breast Imaging (EUSOBI) members, the perceived absence of a clinical need chiefly drove the 50% CEM adoption rate. CEM adoption and progressive experience were associated with more extended current and future indications.

KEY POINTS: • Among the 434 members of the European Society of Breast Imaging who completed this survey, 50% declared to use contrast-enhanced mammography in clinical practice. • Due to the perceived absence of a clinical need, contrast-enhanced mammography (CEM) is still prevalently used as a replacement for MRI in patients with MRI contraindications. • The number of current and future CEM indications marked by respondents was associated with their degree of CEM experience.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Schiaffino S, Cozzi A, Clauser P, et al. Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2024. PMID: 38227202. doi:10.1007/s00330-023-10574-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。